These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17184154)

  • 1. Hypoxia-induced cytosine deaminase gene expression for cancer therapy.
    Lee CH; Wu CL; Shiau AL
    Hum Gene Ther; 2007 Jan; 18(1):27-38. PubMed ID: 17184154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia imaging predicts success of hypoxia-induced cytosine deaminase/5-fluorocytosine gene therapy in a murine lung tumor model.
    Lee BF; Lee CH; Chiu NT; Hsia CC; Shen LH; Shiau AL
    Cancer Gene Ther; 2012 Apr; 19(4):255-62. PubMed ID: 22281757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
    Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
    Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
    Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
    J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
    Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
    Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment.
    Krishnamachary B; Mironchik Y; Jacob D; Goggins E; Kakkad S; Ofori F; Dore-Savard L; Bharti SK; Wildes F; Penet MF; Black ME; Bhujwalla ZM
    Neoplasia; 2020 Dec; 22(12):679-688. PubMed ID: 33142234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma.
    Shneor D; Folberg R; Pe'er J; Honigman A; Frenkel S
    Cancer Gene Ther; 2017 Feb; 24(2):64-74. PubMed ID: 27934882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
    Koshikawa N; Takenaga K; Tagawa M; Sakiyama S
    Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy-driven induction of suicide cytosine deaminase gene.
    Bil J; Wlodarski P; Winiarska M; Kurzaj Z; Issat T; Jozkowicz A; Wegiel B; Dulak J; Golab J
    Cancer Lett; 2010 Apr; 290(2):216-22. PubMed ID: 19822393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
    Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
    Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.
    Chen JK; Hu LJ; Wang D; Lamborn KR; Deen DF
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1538-47. PubMed ID: 17394949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
    Koshikawa N; Takenaga K
    Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
    Pastorakova A; Hlubinova K; Altaner C
    Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting eradication of malignant cells derived from human bone marrow mesenchymal stromal cells.
    Yang Y; Cai S; Yang L; Yu S; Jiang J; Yan X; Zhang H; Liu L; Liu Q; Du J; Cai S; Sung KL
    Exp Cell Res; 2010 Dec; 316(20):3329-41. PubMed ID: 20184882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model.
    Kamlah F; Eul BG; Li S; Lang N; Marsh LM; Seeger W; Grimminger F; Rose F; Hänze J
    Cancer Gene Ther; 2009 Mar; 16(3):195-205. PubMed ID: 18818708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.
    Li L; Zhang CL; Kang L; Wang RF; Yan P; Zhao Q; Yin L; Guo FQ
    Cancer Biother Radiopharm; 2015 Oct; 30(8):342-8. PubMed ID: 26382009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
    Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.